Author

Vivek Gore

Observed names: V. A. Gore, V.A. GORE, V.A. Gore

Institution: Florida Institute of Technology

Observed institutions: Florida Institute of Technology, Eli Lilly (United Kingdom)

OpenAlex ID: A5110133144

Antitumor properties of vindesine-monoclonal antibody conjugates

1985 · G.F. Rowland, C.A. Axton, et al. · Cancer Immunology Immunotherapy · 76

Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograft

1986 · G.F. Rowland, R.G. Simmonds, et al. · Cancer Immunology Immunotherapy · 45

Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids

1987 · J.R.F. Corvalan, W. Smith, et al. · Cancer Immunology Immunotherapy · 37

Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody

1987 · J.R.F. Corvalan, W. Smith, et al. · Cancer Immunology Immunotherapy · 33

Inhibition of 5-Oxo-6,8,11,14-eicosatetraenoic Acid-Induced Activation of Neutrophils and Eosinophils by Novel Indole OXE Receptor Antagonists

2013 · Vivek Gore, Sylvie Gravel, et al. · Journal of Medicinal Chemistry · 28

Tumour therapy with vinca alkaloids targeted by a hybrid-hybrid monoclonal antibody recognising both CEA and vinca alkaloids

1988 · J. R. F. Corvalan, W. Smith, et al. · International Journal of Cancer · 27

5-Oxo-ETE Receptor Antagonists

2013 · Vivek Gore, Pranav Patel, et al. · Journal of Medicinal Chemistry · 20

Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes

2015 · Chantal Cossette, Sylvie Gravel, et al. · Biochemical Pharmacology · 16

Two Potent OXE-R Antagonists: Assignment of Stereochemistry

2014 · Pranav Patel, Chintam Nagendra Reddy, et al. · ACS Medicinal Chemistry Letters · 15

Suppression of Growth of a Human Colorectal Tumour in Nude Mice by Vindesine-Monoclonal ANTI-CEA Conjugates

1984 · G.F. ROWLAND, J.R.F. CORVALAN, et al. · Protides of the biological fluids · 15

Pharmacokinetics and Metabolism of Selective Oxoeicosanoid (OXE) Receptor Antagonists and Their Effects on 5-Oxo-6,8,11,14-eicosatetraenoic Acid (5-Oxo-ETE)-Induced Granulocyte Activation in Monkeys

2016 · Chantal Cossette, Shishir Chourey, et al. · Journal of Medicinal Chemistry · 14

Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine

1990 · W. Smith, V. A. Gore, et al. · Cancer Immunology Immunotherapy · 9

Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys

2018 · Chintam Nagendra Reddy, Hussam Alhamza, et al. · European Journal of Pharmaceutical Sciences · 7

Base-dependent formation of cis and trans olefins and their application in the synthesis of 5-oxo-ETE receptor antagonists

2014 · Vivek Gore, Shishir Chourey, et al. · Bioorganic & Medicinal Chemistry Letters · 7

C20-trifluoro-5-oxo-ETE: A metabolically stable 5-oxo-ETE derivative

2011 · Pranav Patel, Vivek Gore, et al. · Bioorganic & Medicinal Chemistry Letters · 6

A new approach to the synthesis of polyunsaturated deuterated isoprostanes: Total synthesis of d4-5-epi-8,12-iso-iPF3α-VI and d4-8,12-iso-iPF3α-VI

2009 · Chih-Tsung Chang, Pranav Patel, et al. · Bioorganic & Medicinal Chemistry Letters · 3

Works count: 16

Citation count: 358

H-index: 11

I10-index: 11